The U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) has released its first new compliance program guidance since 2008 for health care stakeholders. A broad range of stakeholders have historically relied on this guidance when developing their own compliance programs, particularly when working under contracts and less prescriptive federal and state laws mandating the implementation of such a program.
The new guidance, disclosed on JD Supra, proffers an update to previous standards, reflecting contemporary issues and changes in the healthcare field.
This release represents a key development for healthcare professionals working with large corporations and law firms. Given the influence of HHS OIG guidance on the industry’s compliance programs, changes to these guidelines can have far-reaching and significant impacts on healthcare operations. Considering its nearly decade-long hiatus since the previous update, it’s reasonable to expect that this new guidance incorporates significant changes that healthcare stakeholders and legal professionals must consider closely.
A comprehensive understanding of these revised guidelines is essential for any legal professional working with healthcare providers. Those involved in shaping compliance strategies under these new guidelines must work diligently to ensure that their programs adhere to the stipulated principles while monitoring the potential legal challenges that may ensue from adapting to these novel guidelines.
Indeed, healthcare providers and their legal counsel should take the opportunity to review their existing compliance programs in light of this revised guidance. By doing so, healthcare stakeholders and law firms will ensure that they remain vigilant and responsive to the evolving healthcare compliance landscape, thereby better safeguarding themselves against potential legal issues that might arise with regulatory compliance.